Aflibercept in macular oedema after BRVO: No hint of added benefit

Since February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due to macular oedema that follows blockage of branch veins of the central retinal vein (branch retinal vein occlusion, ...

Diseases, Conditions, Syndromes

FDA issues warning on controversial MS treatment

(HealthDay) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and Drug Administration ...

Diseases, Conditions, Syndromes

Varicose veins keep some in long pants all year

(HealthDay) -- Varicose veins are a cosmetic issue for most people, but they can be a sign of a serious medical problem for others, an expert says.

Medical research

Researchers find new way to prevent dangerous blood clots

(Medical Xpress)—For the first time, scientists at the UNC School of Medicine have shown that eliminating the enzyme factor XIII reduces the number of red blood cells trapped in a clot, resulting in a 50 percent reduction ...

page 8 from 23